CareFusion Corp

CareFusion — Q4 FY2010 Earnings Presentation

17 slides from CareFusion's earnings presentation, Aug 10, 2010

  1. Slide 1: Q4 and Fiscal 2010 Investor/Analyst Call

    Exhibit 99.2 Q4 and Fiscal 2010 Investor/Analyst Call August 10, 2010 © 2010 CareFusion Corporation or one of its subsidiaries. All rights reserved.

  2. Slide 2: Forward-Looking Statements and GAAP Reconciliation

    Forward-Looking Statements and GAAP Reconciliation “Safe Harbor” Statement under the Private Securities Litigation Reform Act of 1995: This presentation contains forward-looking statements addressing expectations, prospects, estimates and other matters that are dependent upon future events or develo

  3. Slide 3: Today's Speakers

    Today’s Speakers • Dave Schlotterbeck, Chairman and Chief Executive Officer • Ed Borkowski, Chief Financial Officer © 2010 CareFusion Corporation or one of its subsidiaries. All rights reserved. 3

  4. Slide 4: Q4 and Fiscal 2010 Results

    Q4 and Fiscal 2010 Results © 2010 CareFusion Corporation or one of its subsidiaries. All rights reserved.

  5. Slide 5: Q4 Fiscal 2010 Year-Over-Year Quarterly Review

    Q4 Fiscal 2010 Year-Over-Year Quarterly Review GAAP Adjusted $M % Change ¹ $M % Change ¹ Revenue $1,035 19% $1,035 19% Operating Expenses ² $362 14% $338 13% Operating Income ² $135 59% $147 44% Income From Continuing $52 (20)% $85 10% Operations ³ Diluted EPS From Continuing $0.23 (23)% $0.38 6% Op

  6. Slide 6: Q4 Fiscal 2010 Year-Over-Year Quarterly Segment Review

    Q4 Fiscal 2010 Year-Over-Year Quarterly Segment Review GAAP Adjusted Critical Care Technologies (CCT) $M % Change ¹ $M % Change ¹ Revenues $716 21% $716 21% Segment Profit ² $106 38% $123 38% Medical Technologies and Services $M % Change ¹ $M % Change ¹ (MTS) Revenues $319 16% $319 16% Segment Profi

  7. Slide 7: Fiscal 2010 Review

    Fiscal 2010 Review GAAP Adjusted $M % Change ¹ $M % Change ¹ Revenue $3,929 9% $3,929 9% Operating Expenses ² $1,406 9% $1,324 9% Operating Income ² $472 6% $542 5% Income From Continuing $171 (41)% $317 0% Operations ³ Diluted EPS From Continuing $0.77 (42)% $1.42 (1)% Operations ³ 1 % Change over

  8. Slide 8: Fiscal 2010 Segment Review

    Fiscal 2010 Segment Review GAAP Adjusted Critical Care Technologies (CCT) $M % Change ¹ $M % Change ¹ Revenues $2,644 9% $2,644 9% Segment Profit ² $395 12% $450 12% Medical Technologies and Services $M % Change ¹ $M % Change ¹ (MTS) Revenues $1,285 10% $1,285 10% Segment Profit ² $65 (28)% $92 (19)

  9. Slide 9: Fiscal 2011 Guidance

    Fiscal 2011 Guidance © 2010 CareFusion Corporation or one of its subsidiaries. All rights reserved.

  10. Slide 10: Impact of FY10 Benefits Not Expected To Reoccur in FY11; FX Fluctuations

    Impact of FY10 Benefits Not Expected To Reoccur in FY11; FX Fluctuations Positive impact on Infusion revenue related to the resumption of sales of Alaris ® System in July 2009 following $60 million 5 months on ship hold Respiratory revenue for flu and emergency preparedness $60 - $65 million related

  11. Slide 11: Fiscal 2011 Guidance

    Fiscal 2011 Guidance $ in millions FY11 Outlook Mid single digits on a reported basis; Total Revenue (percent growth over FY10) mid to high single digits on a constant currency basis Adjusted Operating Expenses 1 33% of total revenue Gross Margin ~48% 1 Adjusted Operating Margin ~15% Adjusted Effect

  12. Slide 12: Fiscal 2011 Assumptions

    Fiscal 2011 Assumptions • Hospital capital spending grows low to mid single digits; customers continue prioritizing spending • Restructuring provides an additional $85 million to $95 million in pre-tax cost savings • Foreign exchange rates remain at current levels • Negative EPS currency impact betw

  13. Slide 13: Fiscal 2011 CCT Segment-related Assumptions vs. Fiscal 2010 Results

    Fiscal 2011 CCT Segment-related Assumptions vs. Fiscal 2010 Results • Segment revenue grows on a percentage basis by mid single digits on a reported and constant currency basis ° Infusion: Revenues grow on a percentage basis in the high teens due to Medegen acquisition and from incremental market sh

  14. Slide 14: Fiscal 2011 MTS Segment-related Assumptions vs. Fiscal 2010 Results

    Fiscal 2011 MTS Segment-related Assumptions vs. Fiscal 2010 Results • Segment revenue grows on a percentage basis by low single digits on a reported basis and mid single digits on constant currency basis ° ChloraPrep ® business grows double digits based on successful execution of growth strategy bot

  15. Slide 15: Q&A

    Q&A © 2010 CareFusion Corporation or one of its subsidiaries. All rights reserved.

  16. Slide 16: Q4 Fiscal 2010 Non-GAAP Reconciliations

    Q4 Fiscal 2010 Non-GAAP Reconciliations FY10 Q4 Nonrecurring FY10 Q4 $ in millions GAAP Items ¹ Adjusted Operating Expenses $362 $(24) $338 Operating Income $135 $12 $147 Income From Continuing Operations $52 $33 $85 Diluted EPS From Continuing $0.23 $0.15 $0.38 Operations ² Critical Care Technologi

  17. Slide 17: Fiscal 2010 Non-GAAP Reconciliations

    Fiscal 2010 Non-GAAP Reconciliations FY10 Nonrecurring FY10 $ in millions GAAP Items ¹ Adjusted Operating Expenses $1,406 $(82) $1,324 Operating Income $472 $70 $542 Income From Continuing Operations $171 $146 $317 Diluted EPS From Continuing $0.77 $0.65 $1.42 Operations ² Critical Care Technologies

CareFusion — Q4 FY2010 Earnings Presentation on 6ix